Are clinical evaluations required for products already approved or is this requirement only for new products? | BradyKnows

Subscribe

I believe the clinical evaluation is required for all products including products that have been approved in China.

Suggested Reading

How should the evaluation of new items in the endpoint table be considered after the implementation of the new…
Can products made from materials conforming to YY 0341.1 Appendix B be exempted from biological evaluation?
Do all medical devices require chemical characterization?
What factors may affect biocompatibility risk when using biological test data from similar devices for…
What are the key focus areas in the evaluation of acute, subacute, subchronic, and chronic toxicity, and can…
How is the endotoxin limit for wound dressing products determined?
GB/T 16886.11-2021 adds tests for subchronic systemic toxicity evaluation with dual-route exposure. Which…
GB/T 16886.1-2022 includes implantation in the biological evaluation of dressings. How should implantation tests…
Why is the extraction period typically 24 hours in China for cytotoxicity testing?

Previous: The regulation (annex I) mentions that ‘During the design development phase, clinical evaluation is required to determine the clinical data needed for premarket product evaluation, to determine whether a clinical trial is needed and the clinical endpoints that need to be observed’ Is that not very similar to the EU Clinical Evaluation Plan? How should it be documented?

Next: We’ve been told to take a “wait & see” approach with regards to the new NMPA guidelines to bypass full clinical investigations for a new ventilator. Are you also in line with a more “relaxed” stance for CER coming from the latest NMPA guidelines?